Junfeng Shi

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Locally Advanced

Cell Proliferation

Vascular Endothelial Growth Factor

Top Venues

Oxidative medicine and cellular longevity

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao Li, Liangliang Wu, Zhiying Zheng, Hanyuan Liu, Haiyang Li, Guoqiang Sun, Guangshun Sun, Ye Cheng, Hanjin Wang, Zhouxiao Li, Junfeng Shi, Weiwei Tang
Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy. Journal of oncology 2022 (2022)
Wei Liang, Junfeng Shi, Haiyan Xia, Xiaowei Wei
A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway. Oxidative medicine and cellular longevity 2021 (2021)
Yueyu Fang, Hui Sun, Yi Chen, Nanyuan Jiang, Lianhua Ji, Junfeng Shi
A rapid response of lung squamous cell carcinoma following treatment with sintilimab combined with recombinant humane endostatin injection and nab-paclitaxel in an elderly patient: A case report. Medicine 100 (31) (2021)